August 31, 2022
8 min listen
Save
Healio Minute Podcast, AMD/Retina Edition: Top Headlines - Week of August 29, 2022
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this edition, macular retinal nerve fiber layer thickness linked with cognitive decline; FDA approves Lucentis biosimilar; advanced visual field loss risk higher after glaucoma diagnosis in Black patients; and more.
Association found between macular retinal nerve fiber layer thickness, cognitive decline
FDA approves Cimerli as interchangeable biosimilar to Lucentis
Black patients have higher risk for advanced visual field loss after glaucoma diagnosis
iStent infinite cleared by FDA
Alcon to acquire Aerie Pharmaceuticals
References:
Kang JH, et al. Transl Vis Sci Technol. 2022;doi:10.1167/tvst.11.7.21.
Kim HM, et al. JAMA Ophthalmol. 2022;doi:10.1001/jamaophthalmol.2022.1563.
Published by:
Sources/Disclosures
Collapse
Disclosures:
Please see each study for relevant financial disclosures.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
